An interlaboratory capillary zone electrophoresis‐UV study of various monoclonal antibodies, instruments, and ε‐aminocaproic acid lots

Author:

Wiesner Rebecca1,Zagst Holger1,Lan Wenkui2,Bigelow Stewart3,Holper Peter4,Hübner Göran5,Josefsson Leila6,Lancaster Claire7,Lo Lili2,Lößner Christopher5,Lu Huixin3ORCID,Neusüß Christian8,Rüttiger Carolin5,Schlecht Johannes8,Schürrle Philipp5,Selsam Alexander5,van der Burg Debbie169ORCID,Wang Shao‐Chun7,Zhu Yunxiao2,Wätzig Hermann1ORCID,Sänger‐van de Griend Cari1610ORCID

Affiliation:

1. Institute of Medicinal and Pharmaceutical Chemistry Technische Universität Braunschweig Braunschweig Germany

2. Bristol Myers Squibb New Brunswick New Jersey USA

3. Health Canada Ottawa Ontario Canada

4. AB SCIEX LLC Redwood City California USA

5. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach an der Riß Germany

6. Kantisto BV Baarn The Netherlands

7. Regeneron Pharmaceuticals, Inc. Tarrytown New York USA

8. Faculty Chemistry Hochschule Aalen Aalen Germany

9. Department of Chemistry School of Engineering Sciences in Chemistry KTH Royal Institute of Technology Stockholm Sweden

10. Department of Medicinal Chemistry Faculty of Pharmacy Uppsala University Uppsala Sweden

Abstract

AbstractCapillary zone electrophoresis ultraviolet (CZE‐UV) has become increasingly popular for the charge heterogeneity determination of mAbs and vaccines. The ε‐aminocaproic acid (eACA) CZE‐UV method has been used as a rapid platform method. However, in the last years, several issues have been observed, for example, loss in electrophoretic resolution or baseline drifts. Evaluating the role of eACA on the reported issues, various laboratories were requested to provide their routinely used eACA CZE‐UV methods, and background electrolyte compositions. Although every laboratory claimed to use the He et al. eACA CZE‐UV method, most methods actually deviate from He's. Subsequently, a detailed interlaboratory study was designed wherein two commercially available mAbs (Waters’ Mass Check Standard mAb [pI 7] and NISTmAb [pI 9]) were provided to each laboratory, along with two detailed eACA CZE‐UV protocols for a short‐end, high‐speed, and a long‐end, high‐resolution method. Ten laboratories participated each using their own instruments, and commodities, showing excellence method performance (relative standard deviations [RSDs] of percent time‐corrected main peak areas from 0.2% to 1.9%, and RSDs of migration times from 0.7% to 1.8% [n = 50 per laboratory], analysis times in some cases as short as 2.5 min). This study clarified that eACA is not the main reason for the abovementioned variations.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,Analytical Chemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3